InsidersTradesSigma
Follow the 케이바이오랩스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 케이바이오랩스 has published 4 public disclosures. Market capitalisation: €22.3bn. The latest transaction was reported on 2 July 2026 (Other). Among the most active insiders: 미래아이앤지. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
케이바이오랩스 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.